K J Rothman

Summary

Publications

  1. ncbi Epidemiological evidence on health risks of cellular telephones
    K J Rothman
    Epidemiology Research Institute, Newton Lower Falls, MA 02462 1450, USA
    Lancet 356:1837-40. 2000
  2. ncbi Research and prevention priorities for alcohol carcinogenesis
    K J Rothman
    Epidemiology, Newton Lower Falls, Massachusetts, USA
    Environ Health Perspect 103:161-3. 1995
  3. ncbi Randomized field trial of vaginal douching, pelvic inflammatory disease and pregnancy
    Kenneth J Rothman
    Ingenix Epidemiology and Safety Research, Auburndale, MA, USA
    Epidemiology 14:340-8. 2003
  4. ncbi Insights into different results from different causal contrasts in the presence of effect-measure modification
    TIL STURMER
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 15:698-709. 2006
  5. ncbi A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods
    TIL STURMER
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    J Clin Epidemiol 59:437-47. 2006
  6. ncbi Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile
    Felix M Arellano
    Risk Management Resources, LLC Bridgewater, NJ 08807, USA
    Pharmacoepidemiol Drug Saf 15:861-72. 2006

Collaborators

  • T STURMER
  • S Schneeweiss
  • Felix M Arellano
  • Charles E Wentworth
  • Marianne Ulcickas Yood
  • Susan A Oliveria
  • Anila Verma
  • Elena Rivero

Detail Information

Publications6

  1. ncbi Epidemiological evidence on health risks of cellular telephones
    K J Rothman
    Epidemiology Research Institute, Newton Lower Falls, MA 02462 1450, USA
    Lancet 356:1837-40. 2000
    ..Cellular telephones affect the quality of our lives in myriad ways, for good and ill; the health risk is just one part of a picture that is slowly coming into focus...
  2. ncbi Research and prevention priorities for alcohol carcinogenesis
    K J Rothman
    Epidemiology, Newton Lower Falls, Massachusetts, USA
    Environ Health Perspect 103:161-3. 1995
    ....
  3. ncbi Randomized field trial of vaginal douching, pelvic inflammatory disease and pregnancy
    Kenneth J Rothman
    Ingenix Epidemiology and Safety Research, Auburndale, MA, USA
    Epidemiology 14:340-8. 2003
    ..Women who douche regularly may do so for reasons related to their risk of acquiring a sexually transmitted infection, introducing confounding that is difficult to control in non-experimental studies...
  4. ncbi Insights into different results from different causal contrasts in the presence of effect-measure modification
    TIL STURMER
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 15:698-709. 2006
    ..In the presence of effect-measure modification, different analytic approaches produce different summary estimates...
  5. ncbi A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods
    TIL STURMER
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    J Clin Epidemiol 59:437-47. 2006
    ..Such analyses have been proposed to address confounding by indication, but there is little empirical evidence that they achieve better control than conventional multivariate outcome modeling...
  6. ncbi Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile
    Felix M Arellano
    Risk Management Resources, LLC Bridgewater, NJ 08807, USA
    Pharmacoepidemiol Drug Saf 15:861-72. 2006
    ..COX-2 and NSAIDS differ in their gastrointestinal (GI) and cardiovascular (CV) toxicity from pharmacological, clinical and epidemiologic point of views...